Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)
Funding to support research activities that will advance NIAIDs mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines. (Source: PHPartners.org)
Source: PHPartners.org - July 19, 2018 Category: International Medicine & Public Health Source Type: news

Nurse-Driven Protocol Increased Vaccination for Flu, Pneumonia
A pilot protocol developed at Memorial Sloan Kettering Cancer Center resulted in exponential increases in both influenza and pneumococcal vaccinations in the outpatient setting. (Source: CancerNetwork)
Source: CancerNetwork - July 12, 2018 Category: Cancer & Oncology Authors: Elizabeth Rodriguez, DNP, RN, OCN Source Type: news

Drop in Childhood Pneumococcal, Hib Deaths From 2000 to 2015
THURSDAY, July 12, 2018 -- Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) deaths in children decreased between 2000 and 2015, following introduction of the pneumococcal conjugate vaccine (PCV) and Hib vaccine, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 12, 2018 Category: Pharmaceuticals Source Type: news

NIAID scientists create 3D structure of 1918 influenza virus-like particles
Details could advance vaccine development for several human diseases. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 11, 2018 Category: American Health Source Type: news

NIAID dcientists create 3D structure of 1918 influenza virus-like particles
(NIH/National Institute of Allergy and Infectious Diseases) Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs aren't infectious, they show promise as vaccine platforms for many viral diseases, including influenza. Since details about influenza VLPs are scant, a team of researchers developed a 3D model based on the 1918 H1 pandemic influenza virus. The research, conducted by NIAID scientists, could benefit VLP vaccine projects, targeting a range of viruses from HIV to Ebola and SARS coronavirus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 11, 2018 Category: Infectious Diseases Source Type: news

What is the Interval For Non-simultaneous Administration of Live Virus Vaccines?
Discussion Vaccines are a mainstay of infectious disease prevention and health promotion. Infants, children and adults benefit from vaccines the most when they are given on the recommended schedules. However there are times when this is not possible as children come to the physician a little early, or a little late, or had unavailable records and so received addition vaccine, etc. There are many questions that arise because of these timing issues such as the one above. Standard vaccine schedules can be reviewed here. Commonly administered vaccines includes: Live-attenuated vaccines Cholera Measles, mumps, rubella (MMR ...
Source: PediatricEducation.org - July 9, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Live and Inactivated Flu Vaccines Have Similar Efficacy in Children Live and Inactivated Flu Vaccines Have Similar Efficacy in Children
Live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) have similar efficacy in children, according to results from a Canadian Immunization Research Network (CIRN) study.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 5, 2018 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

New & Resurgent Infectious Diseases Can Have Far-reaching Economic Repercussions
DAVID E. BLOOM is the Clarence James Gamble Professor of Economics and Demography, DANIEL CADARETTE is a research assistant, and JP SEVILLA is a research associate, all at Harvard University’s T.H. Chan School of Public Health.By David E. Bloom, Daniel Cadarette and JP SevillaWASHINGTON DC, Jul 3 2018 (IPS)Infectious diseases and associated mortality have abated, but they remain a significant threat throughout the world.We continue to fight both old pathogens, such as the plague, that have troubled humanity for millennia and new pathogens, such as human immunodeficiency virus (HIV), that have mutated or spilled over ...
Source: IPS Inter Press Service - Health - July 3, 2018 Category: International Medicine & Public Health Authors: David E. Bloom and JP Sevilla Tags: Active Citizens Development & Aid Economy & Trade Global Headlines Health TerraViva United Nations Source Type: news

Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
NESS ZIONA, Israel, June 28, 2018 -- (Healthcare Sales & Marketing Network) -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), developer of M-001, a clinical phase Universal Influenza Vaccine candidate, announced today the appointment of Mr. Mark Germain a... Biopharmaceuticals, Personnel BiondVax Pharmaceuticals, influenza, influenza vaccine, flu vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 28, 2018 Category: Pharmaceuticals Source Type: news

Impact of Aging and HIV on Serologic Response to Flu Vaccine Impact of Aging and HIV on Serologic Response to Flu Vaccine
In what ways might patient age and HIV status impact seasonal influenza vaccine responses?AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 28, 2018 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Human Vaccines Project and Seqirus partner to advance universal flu vaccine research
(Human Vaccines Project) The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, announced today that Seqirus, a global leader in the prevention of influenza, is joining the Project's Universal Influenza Vaccine Initiative (UIVI). Seqirus, owned by CSL Limited, has been on the front line of influenza vaccine development and pandemic preparedness for more than a century, pioneering new technologies for rapidly producing influenza vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 28, 2018 Category: Infectious Diseases Source Type: news

How the flu virus builds a better mousetrap
(Tufts University, Health Sciences Campus) For the first time, scientists have directly visualized real-time structural changes in the surface protein of the influenza virus that may help the virus fuse with and enter target cells before hijacking them. Single molecules of the protein were found to stretch toward target cells, then refold and try again 5 to 10 times per second. The discovery may help develop more effective vaccines and better understand other viruses, including Ebola, HIV, and SARS. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 28, 2018 Category: Infectious Diseases Source Type: news

ACIP Reaffirms LAIV Recommendation for 2018-19 Flu Season
The CDC's Advisory Committee on Immunization Practices has reaffirmed its October 2017 recommendation to include live attenuated influenza vaccine (LAIV; FluMist) in its guidance for the 2018-19 influenza season. (Source: AAFP News)
Source: AAFP News - June 27, 2018 Category: Primary Care Source Type: news

U.S. government statistics reveal that the flu vaccine is the most dangerous vaccine in America
(Natural News) Even the bestselling flu vaccine is only the fifth most popular vaccine in the United States. Prevnar, the vaccine used to prevent infection caused by pneumococcal bacteria; Gardasil, which supposedly prevents cervical cancer; PENTAct-HIB, given to tiny infants to stave off diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b; and... (Source: NaturalNews.com)
Source: NaturalNews.com - June 22, 2018 Category: Consumer Health News Source Type: news

ACIP Issues Flu Season Guidance, Anthrax Vax in a'Mass Event '
(MedPage Today) -- Committee also heard data on cell-cultured influenza vaccines (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 20, 2018 Category: American Health Source Type: news

A Better Flu Shot May Be On the Horizon. Here ’s Why
Each year, influenza viruses bring aches, pains, fever and overall misery to millions of people. The flu also leads to hundreds of thousands of hospitalizations and thousands of deaths. In a new paper published in Genome Medicine, researchers say a blood test may be able to identify which people are more likely to fight off the flu and which may have a harder time. And information from that same test could lead to new treatments — including more effective vaccines — that might make more people more flu-resistant. For four years, Purvesh Khatri, an associate professor of medicine and biomedical data science at S...
Source: TIME: Health - June 14, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthytime public health Source Type: news

First influenza-specific neuraminidase test kit for flu vaccines
(InDevR, Inc.) InDevR Inc. announced product release of the first ever commercial reagent kit designed explicitly for assessment of neuraminidase (NA) in influenza vaccines. The new kit is poised to help improve influenza vaccines by empowering manufacturers with a standardized method to meet current regulatory requirements and to prepare for future trends. The VaxArray NA kit is an important new tool for a more broadly protective or 'universal' flu vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 12, 2018 Category: Infectious Diseases Source Type: news

Human Vaccines Project announces new partnership with Telethon Kids Institute in Australia
(Human Vaccines Project) The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, today announced its first international scientific hub through a partnership with Telethon Kids Institute. Based in Perth, Western Australia, Telethon Kids Institute is recognized as a world leader in addressing the health of pediatric and indigenous populations. The research institute will   also   join other leading academic, industry, nonprofit and government organizations as a partner of the Project's   Universal Influenza Vaccine Initiative (UIVI). (S...
Source: EurekAlert! - Infectious and Emerging Diseases - June 11, 2018 Category: Infectious Diseases Source Type: news

A Record-Breaking Number of Kids Died During This Year ’s Flu Season
This year’s flu season has killed more children than in any non-pandemic year on record, according to new Centers for Disease Control and Prevention (CDC) data. A total of 172 pediatric deaths have now been reported in connection with the 2017-2018 flu season, including two that occurred as recently as mid- to late-May, according to the CDC. That number edges out the 171 deaths seen in 2012-2013, and surpasses the number of deaths recorded in all but pandemic years, which involve a global outbreak of a new influenza virus, to which most people are not immune. “We saw just an overwhelming amount of flu in gener...
Source: TIME: Health - June 8, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

Update: Influenza Activity in the United States During the 2017 –18 Season and Composition of the 2018–19 Influenza Vaccine
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 7, 2018 Category: American Health Source Type: news

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 7, 2018 Category: American Health Source Type: news

Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine
The 2017-18 influenza season was a high severity, A(H3N2)-predominant season. Influenza activity indicators were notable for the volume and intensity of influenza cases that occurred in most of the country at the same time. Record hospitalization rates and high numbers of influenza-associated pediatric deaths also were reported. (Source: PHPartners.org)
Source: PHPartners.org - June 7, 2018 Category: International Medicine & Public Health Source Type: news

Increase in Requirement for Flu Vaccines at Non-VA Hospitals
TUESDAY, June 5, 2018 -- At non-Veterans Affairs (VA) hospitals, but not in VA hospitals, there was an increase in mandatory influenza vaccination requirements for health care personnel (HCP) from 2013 to 2017, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 5, 2018 Category: Pharmaceuticals Source Type: news

More Hospitals Requiring Influenza Vaccine for Workers More Hospitals Requiring Influenza Vaccine for Workers
The rate went from 37% to 61% in 4 years, with some sectors showing larger jumps than others. Still unclear is whether that will translate into fewer influenza cases among patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Surveillance of influenza and other respiratory viruses in the UK: Winter 2017-18
This report describes influenza activity experienced in UK from week 40, 2017 to week 15, 2018 and includes observations and commentary from the childhood vaccination programme and activity of other seasonal and novel respiratory viruses. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 1, 2018 Category: Consumer Health News Source Type: news

Most hospitals now require workers to get flu shots -- except those that treat veterans
(Michigan Medicine - University of Michigan) A new study shows a rapid rise in the percentage of hospitals that require their workers to be vaccinated against influenza -- except among hospitals that focus on treating the nation's military veterans. The percentage of Veterans Affairs hospitals that have a flu vaccine mandate rose from 1 percent in 2013 to 4 percent in 2017. But at the same time, the percentage of non-VA hospitals requiring shots rose from 44 percent to nearly 70 percent. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 1, 2018 Category: Infectious Diseases Source Type: news

Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015
During its first 10 years (2006-2015), NCIRD worked with partners to improve preparedness and response to pandemic influenza and other emergent respiratory infections, provide an evidence base for addition of 7 newly recommended vaccines, and modernize vaccine distribution. (Source: PHPartners.org)
Source: PHPartners.org - May 30, 2018 Category: International Medicine & Public Health Source Type: news

AAP Favors Flu Shot Over Nasal Spray Vaccine AAP Favors Flu Shot Over Nasal Spray Vaccine
For the upcoming 2018-2019 flu season, the AAP recommends sticking with the inactivated influenza vaccine, which provides better protection; the nasal spray should only be used in kids who refuse shots.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 24, 2018 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Last year's flu vaccine was a total bust, yet the CDC claims it was a "grand success" - Here's the truth of what happened
(Natural News) The Centers for Disease Control (CDC) claims that last year’s flu vaccine was a “grand success.” Newly appointed CDC director Robert R. Redfield claimed the influenza A and B vaccines were 36 percent effective over 2017-2018 flu season. He tweeted praise on the vaccinated because they “reduced risk of getting sick with the... (Source: NaturalNews.com)
Source: NaturalNews.com - May 14, 2018 Category: Consumer Health News Source Type: news

NIAID-Sponsored Trial of a Universal Influenza Vaccine Begins
Phase 2 clinical trial of investigational universal influenza vaccines has begun in the U.S. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 4, 2018 Category: American Health Source Type: news

NIAID-sponsored trial of a universal influenza vaccine begins
(NIH/National Institute of Allergy and Infectious Diseases) A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun. The study is sponsored by the National Institute of Allergy and Infectious Diseases and is being conducted at US sites that are part of the NIAID-funded Vaccine and Treatment Evaluation Units. The trial is testing an experimental vaccine called M-001 for safety and its ability to produce potentially broad protective immune responses. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 4, 2018 Category: Infectious Diseases Source Type: news

Flu Vaccines Have High Impact, Even With Relatively Low Efficacy
MONDAY, April 30, 2018 -- Even relatively low-efficacy influenza vaccines can have a high impact, especially with optimal distribution across age groups, according to a study published online April 30 in the Proceedings of the National Academy of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2018 Category: Pharmaceuticals Source Type: news

Horses Get the Flu, Too
Flu vaccines for horses haven ’t been updated in more than 25 years, but Rochester researchers have developed a new live equine influenza vaccine that is safe and more protective than existing vaccines. A new vaccine is needed not only to keep horses healthy, but also to protect people. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - April 30, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Horses get the flu, too
(University of Rochester Medical Center) Flu vaccines for horses haven't been updated in more than 25 years, but researchers have developed a new live equine influenza vaccine that's safe and more protective than existing vaccines. Proactively preventing the spread of flu in animals is important, as animals are the most likely source of future human pandemics. Animals can be infected with multiple influenza viruses and have the potential to act as 'mixing vessels,' generating new strains that could infect people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2018 Category: International Medicine & Public Health Source Type: news

QuickStats: Percentage of Currently Employed Adults Aged ≥18 Years Who Received Influenza Vaccine in the Past 12 Months, by Employment Category — National Health Interview Survey, United States, 2012 and 2016
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 26, 2018 Category: American Health Source Type: news

VaxArray immunogenicity study published in Vaccine
(InDevR, Inc.) 'VaxArray for Hemagglutinin and Neuraminidase Potency Testing of Influenza Vaccines' describes a study designed to test the relationship between VaxArray-measured potency and vaccine-induced immunogenicity in mice. The study results represent a milestone in an industry-wide effort to qualify new potency assays for influenza vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 26, 2018 Category: Infectious Diseases Source Type: news

Infection prevention specialist nurse named ‘flu fighter champion’
An infection prevention specialist nurse from Yorkshire has been given a national award for her work to encourage influenza vaccination among her trust ’s staff ahead of last winter. (Source: Nursing Times)
Source: Nursing Times - April 25, 2018 Category: Nursing Source Type: news

What Causes Hyponatremia?
Discussion Normal kidneys regulate water balance to maintain a plasma osmolality of 275-290 mOsm/kg normally. Thirst and arginine vasopressin or antidiuretic hormone (ADH) are the primary regulators of plasma osmolality. ADH is made in the hypothalamus and released by the posterior pituitary gland. ADH acts on the kidney’s distal collecting duct to increase water reabsorption. ADH is appropriately released in hypovolemic states, such as dehydration caused by gastroenteritis. ADH has an ~10 minute half-life and therefore can respond to rapid changes in volume status. Sodium balance is regulated by aldosterone (as part...
Source: PediatricEducation.org - April 23, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

World Immunization Week 2018: Protected Together, #VaccinesWork
22 April 2018, Cairo – This year’s World Immunization Week campaign, celebrated from 24 to 30 April, aims to highlight that protecting entire communities with vaccines protects everyone and so the theme of this year’s campaign is “Protected Together, #VaccinesWork”.  Immunization is one of the most successful and cost-effective health interventions. Studies show that every US$ 1 spent on childhood immunization returns US$ 44 in economic and social benefits.  Immunization protects everyone – from infants to senior citizens – against disabling illnesses, disability a...
Source: WHO EMRO News - April 22, 2018 Category: Middle East Health Source Type: news

Fall 2018 flu vaccine will be 20 percent effective, study predicts
This fall's flu vaccine will be 20 percent effective for the dominant circulating strain of influenza A, the same as shots given the past two years. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 19, 2018 Category: Consumer Health News Source Type: news

Kenya:Kenya Doesn't Have a Flu Vaccine Policy. Why It Needs One for Babies
[The Conversation Africa] Each year the World Health Organisation gathers data on influenza strains and recommends which strains countries should include in formulating vaccines for the next year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 19, 2018 Category: African Health Source Type: news

Study predicts 2018 flu vaccine will have 20 percent efficacy
(Rice University) A Rice University study of 6,610 human flu sequences predicts that this fall's flu vaccine will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the vaccine given in 2016 and 2017 due to viral mutations related to vaccine production in eggs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2018 Category: International Medicine & Public Health Source Type: news

VaxArray rapid response to seasonal strain changes for influenza vaccines
(InDevR, Inc.) InDevR expanded its license agreement with the Technology Transfer Program at the US Food and Drug Administration (FDA) to address strain changes recommended by the World Health Organization (WHO) for 2018/2019 seasonal influenza vaccines. The new VaxArray ® Influenza Seasonal HA reagent kit (v2.0) has improved sensitivity to the latest A/H3N2 and B/Victoria-like viruses. Version 2.0 of the potency test is available now for evaluation and will be available for purchase by April 21, 2018. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 10, 2018 Category: Biology Source Type: news

Research offers clues for improved influenza vaccine design
These efforts contribute to NIAID ’s larger plan to develop a universal influenza vaccine. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 6, 2018 Category: American Health Source Type: news

Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed)
Funding to establish, follow, and characterize longitudinal cohorts of infants to determine how initial and repeated natural influenza infections and/or influenza vaccinations shape infant and childhood immunity to future influenza exposures. The ultimate goal of this research is to provide key information to facilitate design of durable, broadly protective influenza vaccines. (Source: PHPartners.org)
Source: PHPartners.org - April 6, 2018 Category: International Medicine & Public Health Source Type: news

A third of health practitioners do not get vaccinated against flu
This NIHR Signal found flu vaccination uptake amongst healthcare workers (HCWs) in England is below NHS target of 75%. This suggests that efforts to improve immunisation uptake must start with education about the benefits of influenza immunisation for HCWs themselves (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 6, 2018 Category: Consumer Health News Source Type: news

Research offers clues for improved influenza vaccine design
(NIH/National Institute of Allergy and Infectious Diseases) Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell. The new research builds on previous studies of NA and was conducted by a team of scientists including investigators from the Centers of Excellence for Influenza Research and Surveillance (CEIRS) program, which is organized and funded by NIAID. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 6, 2018 Category: Infectious Diseases Source Type: news

For a better influenza vaccine, focus on the neglected 'N'
(University of Chicago Medical Center) In the April 5, 2018, issue of the journal Cell, researchers push for greater emphasis on the neglected viral-surface influenza protein neuraminidase. For decades, flu vaccines have concentrated on hemagglutinin. The authors maintain that a focus on neuraminidase could lower infection rates and lessen severity. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 5, 2018 Category: Infectious Diseases Source Type: news

In promoting vaccination, behavioral strategies more effective than persuasion
(Association for Psychological Science) Faced with outbreaks of influenza and other vaccine-preventable diseases, parents, educators, healthcare providers, and policymakers around the world often want to know how to persuade people to get their vaccinations. But a comprehensive review of the scientific findings from research on vaccination behavior shows that the most effective interventions focus directly on shaping patients' and parents' behavior instead of trying to change their minds. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 4, 2018 Category: International Medicine & Public Health Source Type: news

Recombinant Influenza Vaccine Found to Be Safe in Children
MONDAY, April 2, 2018 -- The recombinant influenza vaccine (RIV4) is well tolerated in children aged 6 to 17 years, and it provides immunogenicity comparable to that of the inactivated vaccine, according to a study published online April 2 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 2, 2018 Category: Pharmaceuticals Source Type: news